Published in Surgery on March 01, 1987
Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol. South Med J (2009) 1.15
Colonic mucosal necrosis following administration of calcium polystryrene sulfonate (Kalimate) in a uremic patient. J Korean Med Sci (2009) 1.06
Colonic necrosis and perforation due to calcium polystyrene sulfonate in a uraemic patient: a case report. NDT Plus (2011) 0.97
Kayexalate Intake (in Sorbitol) and Jejunal Diverticulitis, a Causative Role or an Innocent Bystander? Case Rep Gastroenterol (2007) 0.91
Gastrointestinal disorders and renal failure: exploring the connection. Nat Rev Nephrol (2010) 0.89
Development of Colonic Perforation during Calcium Polystyrene Sulfonate Administration: A Case Report. Case Rep Med (2013) 0.85
Colonic necrosis due to sodium polystyrene sulfate (Kayexalate). Am J Emerg Med (2009) 0.81
To bind or to let loose: effectiveness of sodium polystyrene sulfonate in decreasing serum potassium. Int J Nephrol (2012) 0.81
Ileocolic perforation secondary to sodium polystyrene sulfonate in sorbitol use: a case report. Can J Gastroenterol (2009) 0.78
Chronic renal failure, hyperkalemia, and colonic ulcers. Indian J Nephrol (2014) 0.75
Total colectomy for colon perforation after kayexalate administration: a case report and literature review of a rare complication. J Surg Case Rep (2016) 0.75
Resin-Induced Colonic Pseudotumor: Rare Complication from Chronic Use of Potassium Binders in a Hemodialysis Patient. Case Rep Nephrol (2016) 0.75
Cation Exchange Resins and colonic perforation. What surgeons need to know. Int J Surg Case Rep (2015) 0.75
The use of histological techniques for the demonstration of ion exchange resins. J Clin Pathol (1999) 0.75
Sigmoid colon diverticula perforation associated with sevelamer hydrochloride administration: A case report. Ann Med Surg (Lond) (2016) 0.75
Colon Necrosis Due to Sodium Polystyrene Sulfonate with and without Sorbitol: An Experimental Study in Rats. PLoS One (2015) 0.75
Medication-associated gastrointestinal tract injury. Virchows Arch (2017) 0.75
Treatment of Hyperkalemia in Heart Failure. Curr Heart Fail Rep (2017) 0.75
An unusual cause of recurrent right lower quadrant pain. Dig Dis Sci (2014) 0.75
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66
Gene expression profiles in normal and cancer cells. Science (1997) 9.65
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 9.23
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg (1997) 8.86
Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg (2001) 8.34
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet (1994) 8.34
Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A (1987) 7.12
Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun (1985) 6.57
Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science (1991) 6.15
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res (1999) 6.10
One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg (1993) 5.87
Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst (1997) 5.68
Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg (1995) 5.66
Double-masked randomized trial comparing alternate combinations of intraoperative anesthesia and postoperative analgesia in abdominal aortic surgery. Anesthesiology (2001) 5.54
Allelotype of colorectal carcinomas. Science (1989) 5.54
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med (2001) 5.22
Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med (1994) 5.12
Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med (1997) 4.66
Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med (1987) 4.55
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet (1997) 4.46
Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol (1994) 4.43
Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res (1987) 4.25
A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg (1995) 4.24
Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg (1998) 4.19
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 4.09
Molecular diagnosis of familial adenomatous polyposis. N Engl J Med (1993) 4.07
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet (1995) 4.01
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg (1997) 3.90
Clonal analysis of human colorectal tumors. Science (1987) 3.72
Hypomethylation of DNA from benign and malignant human colon neoplasms. Science (1985) 3.72
Identification of p53 gene mutations in bladder cancers and urine samples. Science (1991) 3.68
The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology (1992) 3.59
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (1992) 3.58
Mismatch repair deficiency in phenotypically normal human cells. Science (1995) 3.55
Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A (2001) 3.51
"Hyperacute" renal-homograft rejection in man. N Engl J Med (1968) 3.37
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol (2001) 3.27
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg (1993) 3.17
Pyogenic hepatic abscess. Changing trends over 42 years. Ann Surg (1996) 3.13
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res (1995) 3.13
International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int (1993) 3.11
Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res (1997) 3.09
Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07
Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants. Ann Surg (1966) 3.06
Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology (1982) 2.95
Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg (2000) 2.94
Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst (2001) 2.93
Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med (1998) 2.91
Histopathological identification of colon cancer with microsatellite instability. Am J Pathol (2001) 2.90
Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev (2001) 2.85
Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg (2001) 2.80
Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77
An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol (1994) 2.67
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62
Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg (1998) 2.60
Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol (1997) 2.57
Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg (1997) 2.53
Mad-related genes in the human. Nat Genet (1996) 2.51
Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science (1985) 2.49
Laparoscopic cholecystectomy-related bile duct injuries: a health and financial disaster. Ann Surg (1997) 2.41
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg (1999) 2.37
Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg (1999) 2.36
The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol (1987) 2.31
Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]. JAMA (1989) 2.29
A prospective longitudinal study of social, psychological and obstetric factors in pregnancy: response rates and demographic characteristics of the 8556 respondents. Br J Obstet Gynaecol (1989) 2.27
Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination. Am J Transplant (2011) 2.26
N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther (1996) 2.24
A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol (2007) 2.21
Genotoxicity and carcinogenicity in rats and mice of 2-amino-3,6-dihydro-3-methyl-7H-imidazolo[4,5-f]quinolin-7- one: an intestinal bacterial metabolite of 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline. J Natl Cancer Inst (1994) 2.21
Laparoscopic cholecystectomy. Surg Clin North Am (1990) 2.11
Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust (1995) 2.10
Desmoid tumours in familial adenomatous polyposis. Gut (1994) 2.08
Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology (1984) 2.08
Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. Gastroenterology (1996) 2.07
High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci U S A (1991) 2.07
Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg (2000) 2.00
Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol (1987) 1.97
Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst (1993) 1.94
Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol (1997) 1.93
Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut (1996) 1.89
CpG island methylation in colorectal adenomas. Am J Pathol (2001) 1.88
The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology (1995) 1.86
Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology (2000) 1.86
Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg (2000) 1.86
Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut (1993) 1.85